Hypofractionated Radiotherapy for Localized Prostate Cancer (With CyberKnife or With IMRT)
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
PSA response that achieves a stable nadir over time.
Christopher R. King
United States: Food and Drug Administration
|Stanford University School of Medicine||Stanford, California 94305-5317|